Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sexual dysfunction in women with hyperprolactinemia: a pilot study report.

Pinar Kadioglu1, Ayse Serap Yalin, Ozay Tiryakioglu

  • 1Department of Internal Medicine (Division of Endocrinology and Metabolism), Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey. kadioglu@yahoo.com

The Journal of Urology
|October 12, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-sectional comparison of cardiometabolic markers in transgender men receiving gender-affirming hormone therapy.

Endocrine·2026
Same author

Unveiling the role of galectin-3 in patients with azoospermia: potential biomarker for male infertility.

Zygote (Cambridge, England)·2026
Same author

Does persistent hyperprolactinemia contribute to bone loss independently of estrogen deficiency in postmenopausal women?

Pituitary·2026
Same author

ZEB1-AS1 and miR-200b-3p Expression in Non-Muscle-Invasive Bladder Cancer: Pathological Correlates.

Journal of clinical medicine·2026
Same author

Differences in Clinical Outcomes Between Patients With Incidentally Detected and Clinically Detected Pheochromocytomas and Paragangliomas: A Retrospective Multicenter Study.

Clinical endocrinology·2026
Same author

Correction: Penile prosthesis implantation: a systematic review of intraoperative and postoperative complications.

International journal of impotence research·2026

Women with hyperprolactinemia experience significant sexual dysfunction, with 88% diagnosed with female sexual dysfunction (FSD). Elevated prolactin levels negatively correlate with sexual function domains, indicating a direct impact on women's sexual health.

Area of Science:

  • Endocrinology
  • Reproductive Health
  • Sexual Medicine

Background:

  • Hyperprolactinemia is a common endocrine disorder in women.
  • It can potentially impact various aspects of female sexual function (FSD).

Purpose of the Study:

  • To investigate the prevalence and characteristics of sexual dysfunction in women with hyperprolactinemia.
  • To compare sexual function between women with hyperprolactinemia and healthy controls.

Main Methods:

  • A cohort of 25 women with hyperprolactinemia and 16 age-matched healthy women were assessed.
  • Evaluations included detailed medical and sexual histories, the Female Sexual Function Index (FSFI), and the Beck Depression Inventory.
  • Serum levels of prolactin and other relevant hormones were measured and compared between groups.

Related Experiment Videos

Main Results:

  • Women with hyperprolactinemia exhibited significantly lower total FSFI scores compared to controls (23.40 vs. 31.10).
  • Female sexual dysfunction (FSD) was diagnosed in 88% of hyperprolactinemic women versus 25% of controls.
  • Lower scores in desire, arousal, lubrication, orgasm, and pain domains were observed in the hyperprolactinemia group, with negative correlations between prolactin levels and FSFI scores.

Conclusions:

  • A high percentage of women with hyperprolactinemia suffer from sexual dysfunction.
  • Elevated prolactin levels, not other hormonal changes or depression, were identified as a significant factor contributing to FSD in this population.